Crescent Biopharma, Inc.

Crescent Biopharma, Inc.

CBIO
Crescent Biopharma, Inc.US flagNASDAQ Capital Market
16.64
USD
+1.59
- -
458.80MMarket Cap

Crescent Biopharma, Inc. (CBIO) Stock Split History

Learn about Crescent Biopharma, Inc.'s most recent 1-for-100 basis stock split on June 16, 2025. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Crescent Biopharma, Inc.'s most recent stock split

Split Date: 2025-06-16
Split Ratio: 1:100
Price Before Split: $0.16
Price After Split: $0.00

Developer API

Get CBIO split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/CBIO

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 100.00 times fewer shares (a 1:100 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Crescent Biopharma, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2025-06-161:100Yes$0.16$0.00

About Crescent Biopharma, Inc.

Company overview and industry information

Crescent Biopharma, Inc. (CBIO) operates in the Biotechnology industry. The recent 1-for-100 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Crescent Biopharma, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.